Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tunica intima endothelial receptor tyrosine kinase 2 (Tie2) is an endothelial-specific receptor tyrosine kinase crucial for angiogenesis. Ligands Angiopoietin-1 (Ang1) and Angiopoietin-2 (Ang2) regulate vascular quiescence versus remodeling by modulating interactions between endothelial cells and their environment. Tie2 signaling maintains blood vessel integrity by promoting endothelial cell survival, regulating vascular permeability and modulating inflammatory responses. Altered expression or function of Tie2/angiopoietins contributes to abnormal angiogenesis or increased plaque vulnerability in atherosclerosis in pathological states like cancer or diabetes.
Agonist or antagonist binding to the extracellular domain, modulating tyrosine kinase activity and downstream signaling pathways related to vascular stability and permeability.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tunica Intima Endothelial Receptor Tyrosine Kinase 2 (Tie2).